Synapse - Patrick William Burke

Patrick William Burke

Research Focus

Former Employee. Graduate Staff; Fellow

Recent additions – View all

A phase 1, multicenter, open-label, dose-escalation study to evaluate safety, tolerability, pharmacokinetics, and clinical activity of orally administered LP-108 (lacutoclax) as monotherapy and in combination with azacitidine in subjects with relapsed or refractory myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML)
Meeting Abstract

Burgues, J. M. B.; Koenig, K.; Montesinos, P.; Bixby, D. L.; Burke, P. W.; Daver, N.; Anthony, S. P.; Tan, F. L.; Chen, Y.; Chen, Y.; more...
Blood (2024)

Fulltext@MSK | Save
Frequency and characteristics of pegaspargase antibodies in adults treated with a pediatric acute lymphoblastic leukemia regimen
Meeting Abstract

Burke, P. W.; Aldoss, I.; Ramezani, L.; Pullarkat, V.; Mohrbacher, A.; Douer, D.
Blood (2014)

Fulltext@MSK | Save
Acute lymphoblastic leukemia in adolescents and young adults
Journal Article

Burke, P. W.; Douer, D.
Acta Haematologica (2014)

Fulltext@MSK | Save

Co-authors at MSK

5

Douer
3

Tallman
2

Lunning
2

Park
1

Hassoun
1

Iyengar
1

Kumar
1

Landau
1

Palomba
1

Parames...
1

Rampal
1

Shoushtari
1

Smith
1

Soff
1

Soriano
1

Wuest

Types of Work

Publications